Provided by Tiger Trade Technology Pte. Ltd.

Assembly Biosciences

35.21
+0.83202.42%
Volume:163.42K
Turnover:5.73M
Market Cap:716.94M
PE:-13.72K
High:35.76
Open:34.38
Low:33.75
Close:34.38
52wk High:39.71
52wk Low:20.23
Shares:20.36M
Float Shares:9.17M
Volume Ratio:1.13
T/O Rate:1.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0026
EPS(LYR):-0.5461
ROE:-0.03%
ROA:-2.67%
PB:2.35
PE(LYR):-64.48

Loading ...

Assembly Biosciences Closes Securities Offering

MT Newswires Live
·
May 27

Assembly Biosciences Completes Significant Equity Offering Financing

TIPRANKS
·
May 27

Assembly Biosciences closes USD 115 million follow-on stock, pre-funded warrant offering at USD 26.5 per share

Reuters
·
May 27

Press Release: Assembly Biosciences Announces the Closing of its Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Dow Jones
·
May 27

Assembly Biosciences Prices $100 Million Offering

MT Newswires Live
·
May 22

Assembly Bio prices USD 100 million follow-on offering at USD 26.5 per share

Reuters
·
May 22

Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
May 22

Assembly Biosciences Inc - Prices 3.4 Mln Shares at $26.50 and 415,000 Pre-Funded Warrants at $26.499 Each

THOMSON REUTERS
·
May 22

Assembly Biosciences Inc: Plans to Initiate a Phase 2 Clinical Study of Abi-6250 in Hdv in Q4 of 2026

THOMSON REUTERS
·
May 22

Assembly Biosciences Announces Expansion of Abi-6250 Clinical Development Into Cholestatic Liver Diseases

THOMSON REUTERS
·
May 22

Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases

GlobeNewswire
·
May 22

Analyst Reiterates Buy on Assembly Biosciences, Maintains $50 Price Target Amid Pipeline Progress and 2028 Cash Runway

TIPRANKS
·
May 14

Assembly Bio to present topline Phase 1a data for HDV entry inhibitor ABI-6250 at EASL 2026

Reuters
·
May 13

Assembly Biosciences to Present at the BofA Securities 2026 Global Health Care Conference

GlobeNewswire
·
May 11

Guggenheim Sticks to Its Buy Rating for Assembly Biosciences (ASMB)

TIPRANKS
·
May 11

Assembly Biosciences posts corporate presentation on antiviral pipeline for herpesviruses, hepatitis B and D

Reuters
·
May 08

Assembly Biosciences Q1 revenue falls, net loss widens

Reuters
·
May 08

Assembly Biosciences Q1 EPS $(0.54) Beats $(0.71) Estimate, Sales $8.213M Miss $9.266M Estimate

Benzinga Earnings
·
May 08

Assembly Bio Q1 FY26 net loss narrows to $9.1 million; revenue slips to $8.2 million

Reuters
·
May 08

Assembly Biosciences Q1 EPS USD -0.54

THOMSON REUTERS
·
May 08